NASDAQ:IMA ImageneBio Q3 2026 Earnings Results & Report $3.65 -0.32 (-8.06%) As of 03:12 PM Eastern This is a fair market value price provided by Massive. Learn more. ImageneBio missed analyst earnings expectations in its Q3 2026 results, released November 9, 2026. The company reported EPS of -$0.91 versus the -$0.83 consensus estimate. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ3 2026Report DateNovember 9, 2026TimeAfter Market ClosesConference Call7:00 AM ET ImageneBio EPS ResultsActual EPS-$0.91Consensus EPS -$0.83Beat/MissMissed by -$0.08One Year Ago EPSN/AEPS Beat Rate5 of last 8 quartersImageneBio Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) ImageneBio Q3 2026 Earnings FAQ Did ImageneBio beat earnings estimates for Q3 2026? ImageneBio (NASDAQ:IMA) reported earnings of -$0.91 per share for Q3 2026, missing the consensus estimate of -$0.83. The report was announced on Monday, November 9, 2026. ImageneBio Earnings HeadlinesImageneBio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 20262 hours ago | marketscreener.comMImageneBio Reports Third Quarter 2026 Financial ResultsNovember 9 at 4:05 PM | globenewswire.comA free stock pick, from me to youElon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Without its chip, his AI satellites don't fly. Now he wants 1,000,000 of them in orbit, 100 times what's up there today, and every one pays this company a royalty. Dylan believes shares could react by December 8th.November 10 at 1:00 AM | Behind the Markets (Ad)ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)October 2, 2026 | globenewswire.comImageneBio Corporate Event Calendar | NASDAQ:IMASeptember 13, 2026 | benzinga.comImageneBio to Participate in H.C. Wainwright 28th Annual Global Investment Conference in New YorkSeptember 8, 2026 | markets.businessinsider.comSee More ImageneBio Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like ImageneBio? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ImageneBio and other key companies, straight to your email. Email Address About ImageneBioImageneBio (NASDAQ:IMA) is a biotechnology company focused on advancing precision oncology through blood-based molecular testing and data analysis. The company develops technologies designed to help identify and monitor cancer-related genomic signals using liquid biopsy samples. Its platform is intended to support the detection and tracking of tumor biomarkers, potentially helping clinicians assess treatment response, identify disease progression, and guide more personalized cancer-care decisions. ImageneBio combines molecular analysis with computational tools to translate circulating biological information into insights for oncology research and clinical use. The company’s offerings are directed primarily toward cancer patients, healthcare providers, pharmaceutical companies, and research organizations involved in drug development and precision medicine. Publicly available information about ImageneBio’s historical development, geographic operations, and leadership is limited.View ImageneBio ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles D-Wave Quantum Has Long-Term Potential, But Is Now the Time to Buy?Archer Aviation's FAA Certificate Is a Milestone, But It Isn't the Final OneDraftKings Just Lost 20%—And Its Biggest Gamble Is Still AheadBarrick's Earnings Beat Could Be Overshadowed by an Even Bigger OpportunityAxon vs. Motorola: Which Public Safety Stock Has More Upside After Q3 Earnings?Microsoft’s Neocloud Pullback Isn’t a Crack in AI DemandOklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next? Upcoming Earnings Brookfield (11/12/2026)NU (11/12/2026)Applied Materials (11/12/2026)Cisco Systems (11/12/2026)Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026)Sumitomo Mitsui Financial Group (11/13/2026)Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
